Houston startup names new exec, innovators join prestigious program, and more news

short stories

Here's your latest roundup of Houston innovation news you may have missed. Photo by Tim Leviston/Getty Images

Houston's cooling down, but the city's innovation news is heating up, and there might be some headlines you may have missed.

In this roundup of short stories within Houston startups and tech, a Houston startup has a new C-level exec, two innovators join a international cohort of leaders, and more.

NanoTech names new chief commercial officer

Carrie Horazeck is now the chief commercial officer for NanoTech. Photo courtesy of NanoTech

Houston-based materials science company NanoTech Inc. has appointed Carrie Horazeck as chief commercial officer for the startup, which created a fireproofing and carbon reduction through cool roof coatings. In her new role, Horazeck will lead marketing and sales strategy for the growing company.

“I’ve been a fan of NanoTech since I first met co-founder and CEO Mike Francis at a Halliburton Labs event last year," Horazeck says in a statement. “It’s an incredible team, with an incredible product. They are on the precipice of major growth and I’m very honored to be a part of that journey.”

Prior to NanoTech, Horazeck spent 11 years in management consulting helping to grow her clients' businesses, staying tuned into consumer trends and behaviors to guide product development and intelligent marketing strategy. She's worked with a wide range of industries and clients including Samsung, General Mills, Newell Brands, Coca-Cola, Unilever, American Express, British American Tobacco, Anheuser-Busch, and the Department of Education in New York City. Most recently, she led commercial development and market penetration strategy for an Austin based startup in the renewable energy space.

"We are excited to have Carrie join the NanoTech team. She is going to help us get one step closer to our goal of reducing carbon emissions with our cool roof coating and fireproofing critical infrastructure," says Francis in the statement.

2 Houstonians named to global cohort

Houstonians Allie Danziger and Natasha McDaniel were announced to be joining the Fall 2022 Milestone Makers cohort. Photos courtesy

Two Houston innovators have been named to Nasdaq Entrepreneurial Center's Fall 2022 Milestone Makers cohort, which selects individuals addressing the United Nation's Sustainable Development Goals.

The virtual, 12-week program provides individualized mentorship and executive coaching, as well as access to the Center’s vast network of industry experts to help each founder with his or her milestone. The new cohort was selected through application process, and all hope to improve the lives of and support communities across the globe. The two Houstonians in the current cohort include:

  •  Allie Danziger of Ampersand, which enhances employee retention by ensuring mastery in key skills required for entry-level professionals.
  • Natasha McDaniel of Lit for Life, which offers culturally relevant reading and writing resources as well as family coaching and educational consulting services.

Applications are open for the Winter 2023 program are now open.

Houston robotics company to ring the bell on Wall Street

The Nasdaq Bell Ringing Ceremony for Nauticus Robotics, Inc. will take place this Thursday. Image via LinkedIn

Houston-based Nauticus Robotics, which went public last month via SPAC, is due to ring the Nasdaq bell on Wall Street.

The company, which now trades under the $KITT ticker, will have its bell ringing ceremony beginning at 2:45 p.m. CT on October 20 and can be viewed via this link.

Nauticus continues to be led by CEO Nicolaus Radford and the current executive team.

“The closing of this business combination represents a pivotal milestone in our company’s history as we take public our pursuit of transforming the ocean robotics industry with autonomous systems,” Radford, who founded what was known as Houston Mechatronics in 2014, said in a news release about the IPO. “Not only is the ocean a tremendous economic engine, but it is also the epicenter for building a sustainable future.”

UH named 2022 Hispanic Serving Institution Leader by U.S. Fulbright program

UH — and its students — have been recognized by the Fulbright organization. Photo courtesy of UH

For the second year in a row, the University of Houston has been named as a 2022 Fulbright Hispanic Serving Institution Leader.

“As the state’s premier Hispanic-Serving Institution and a top Fulbright producer, the University of Houston strives to ensure an environment of inclusion and success for all,” said UH President Renu Khator. “This recognition is yet another milestone that reinforces what so many already know about our institution … that our students are supported both culturally and academically.”

The recognition was announced the Hispanic Association of Colleges and Universities annual conference in San Diego on Oct. 10.

The University of Houston recently announced 10 student Fulbright recipients, each prepared to travel far and wide to gain international insights, according to the news release. Since 2018, nearly 50 Fulbright scholarships have been awarded to UH students.

“Enhancing learning and research experiences for students and faculty through the Fulbright Program is important to expanding the University’s international footprint,” says Michael Pelletier, executive director of UH’s Institute for Global Engagement in the release.

Texas investor named among outstanding women in clean energy

Phoebe Wang was honored for her work at Shell Ventures. Photo via LinkedIn

The U.S. Department of Energy recently announced the nine winners of the 2022 Clean Energy Education & Empowerment Awards that honors women for outstanding leadership and accomplishments in clean energy.

“For too long, there has been a significant gender gap in the energy sector, meaning half the population have had a minimized impact on one of our most important industries,” says U.S. Secretary of Energy Jennifer M. Granholm in a news release. “As we transition to a clean energy economy, we will have to tap into the pool of amazing women working in energy and grow their ranks. That’s why DOE is proud to recognize the winners of this year’s C3E Awards, a diverse group of changemaking women tackling some of the biggest challenges in energy.”

Among the honorees, Phoebe Wang, formerly of Shell Ventures and based in Texas, was recognized in the business category. Wang "leads investments in early- and late-stage startups working on technologies to accelerate the energy transition in the areas of hydrogen, carbon capture utilization and storage, energy storage, mobility, and power," per the release. In the past decade, she has invested more than $150 million startups and has been closely involved in the Rice Alliance for Technology and Entrepreneurship. Last week, Wang was announced to be joining the Amazon Climate Pledge Fund as investment partner.

Now in its 11th year, the C3E Inititive led by the DOE — in collaboration with the MIT Energy Initiative, Stanford University’s Precourt Institute for Energy, and the Texas A&M Energy Institute — will award each winner with a cash gift of $8,000 and national recognition of their efforts.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Property Showcase

Greentown Labs names Lawson Gow as its new Houston leader

head of hou

Greentown Labs has named Lawson Gow as its Head of Houston.

Gow is the founder of The Cannon, a coworking space with seven locations in the Houston area, with additional partner spaces. He also recently served as managing partner at Houston-based investment and advisory firm Helium Capital. Gow is the son of David Gow, founder of Energy Capital's parent company, Gow Media.

According to Greentown, Gow will "enhance the founder experience, cultivate strategic partnerships, and accelerate climatetech solutions" in his new role.

“I couldn’t be more excited to join Greentown at this critical moment for the energy transition,” Gow said in a news release. “Greentown has a fantastic track record of supporting entrepreneurs in Houston, Boston, and beyond, and I am eager to keep advancing our mission in the energy transition capital of the world.”

Gow has also held analyst, strategy and advising roles since graduating from Rice University.

“We are thrilled to welcome Lawson to our leadership team,” Georgina Campbell Flatter, CEO of Greentown Labs, added in the release. “Lawson has spent his career building community and championing entrepreneurs, and we look forward to him deepening Greentown’s support of climate and energy startups as our Head of Houston.”

Gow is the latest addition to a series of new hires at Greentown Labs following a leadership shakeup.

Flatter was named as the organization's new CEO in February, replacing Kevin Dutt, Greentown’s interim CEO, who replaced Kevin Knobloch after he announced that he would step down in July 2024 after less than a year in the role.

Greentown also named Naheed Malik its new CFO in January.

Timmeko Moore Love was named the first Houston general manager and senior vice president of Greentown Labs. According to LinkedIn, she left the role in January.

---

This article originally appeared on our sister site, EnergyCapitalHTX.com.

Houston foundation grants $27M to support Texas chemistry research

fresh funding

Houston-based The Welch Foundation has doled out $27 million in its latest round of grants for chemical research, equipment and postdoctoral fellowships.

According to a June announcement, $25.5 million was allocated for the foundation's longstanding research grants, which provide $100,000 per year in funding for three years to full-time, regular tenure or tenure-track faculty members in Texas. The foundation made 85 grants to faculty at 16 Texas institutions for 2025, including:

  • Michael I. Jacobs, assistant professor in the chemistry and biochemistry department at Texas State University, who is investigating the structure and thermodynamics of intrinsically disordered proteins, which could "reveal clues about how life began," according to the foundation.
  • Kendra K. Frederick, assistant professor in the biophysics department at The University of Texas Southwestern Medical Center, who is studying a protein linked to Parkinson’s disease.
  • Jennifer S. Brodbelt, professor in chemistry at The University of Texas at Austin, who is testing a theory called full replica symmetry breaking (fullRSB) on glass-like materials, which has implications for complex systems in physics, chemistry and biology.

Additional funding will be allocated to the Welch Postdoctoral Fellows of the Life Sciences Research Foundation. The program provides three-year fellowships to recent PhD graduates to support clinical research careers in Texas. Two fellows from Rice University and Baylor University will receive $100,000 annually for three years.

The Welch Foundation also issued $975,000 through its equipment grant program to 13 institutions to help them develop "richer laboratory experience(s)." The universities matched funds of $352,346.

Since 1954, the Welch Foundation has contributed over $1.1 billion for Texas-nurtured advancements in chemistry through research grants, endowed chairs and other chemistry-related ventures. Last year, the foundation granted more than $40.5 million in academic research grants, equipment grants and fellowships.

“Through funding basic chemical research, we are actively investing in the future of humankind,” Adam Kuspa, president of The Welch Foundation, said the news release. “We are proud to support so many talented researchers across Texas and continue to be inspired by the important work they complete every day.”

New Houston biotech co. developing capsules for hard-to-treat tumors

biotech breakthroughs

Houston company Sentinel BioTherapeutics has made promising headway in cancer immunotherapy for patients who don’t respond positively to more traditional treatments. New biotech venture creation studio RBL LLC (pronounced “rebel”) recently debuted the company at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.

Rima Chakrabarti is a neurologist by training. Though she says she’s “passionate about treating the brain,” her greatest fervor currently lies in leading Sentinel as its CEO. Sentinel is RBL’s first clinical venture, and Chakrabarti also serves as cofounder and managing partner of the venture studio.

The team sees an opportunity to use cytokine interleukin-2 (IL-2) capsules to fight many solid tumors for which immunotherapy hasn't been effective in the past. “We plan to develop a pipeline of drugs that way,” Chakrabarti says.

This may all sound brand-new, but Sentinel’s research goes back years to the work of Omid Veiseh, director of the Rice Biotechnology Launch Pad (RBLP). Through another, now-defunct company called Avenge Bio, Veiseh and Paul Wotton — also with RBLP and now RBL’s CEO and chairman of Sentinel — invested close to $45 million in capital toward their promising discovery.

From preclinical data on studies in mice, Avenge was able to manufacture its platform focused on ovarian cancer treatments and test it on 14 human patients. “That's essentially opened the door to understanding the clinical efficacy of this drug as well as it's brought this to the attention of the FDA, such that now we're able to continue that conversation,” says Chakrabarti. She emphasizes the point that Avenge’s demise was not due to the science, but to the company's unsuccessful outsourcing to a Massachusetts management team.

“They hadn't analyzed a lot of the data that we got access to upon the acquisition,” explains Chakrabarti. “When we analyzed the data, we saw this dose-dependent immune activation, very specific upregulation of checkpoints on T cells. We came to understand how effective this agent could be as an immune priming agent in a way that Avenge Bio hadn't been developing this drug.”

Chakrabarti says that Sentinel’s phase II trials are coming soon. They’ll continue their previous work with ovarian cancer, but Chakrabarti says that she also believes that the IL-2 capsules will be effective in the treatment of endometrial cancer. There’s also potential for people with other cancers located in the peritoneal cavity, such as colorectal cancer, gastrointestinal cancer and even primary peritoneal carcinomatosis.

“We're delivering these capsules into the peritoneal cavity and seeing both the safety as well as the immune activation,” Chakrabarti says. “We're seeing that up-regulation of the checkpoint that I mentioned. We're seeing a strong safety signal. This drug was very well-tolerated by patients where IL-2 has always had a challenge in being a well-tolerated drug.”

When phase II will take place is up to the success of Sentinel’s fundraising push. What we do know is that it will be led by Amir Jazaeri at MD Anderson Cancer Center. Part of the goal this summer is also to create an automated cell manufacturing process and prove that Sentinel can store its product long-term.

“This isn’t just another cell therapy,” Chakrabarti says.

"Sentinel's cytokine factory platform is the breakthrough technology that we believe has the potential to define the next era of cancer treatment," adds Wotton.

View All Listings